CHARLES SCHWAB INVESTMENT MANAGEMENT INC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,472,092
+101.2%
765,320
+194.6%
0.00%
+100.0%
Q2 2023$4,210,418
+589.6%
259,742
+608.4%
0.00%
Q1 2023$610,522
+124.2%
36,668
+26.6%
0.00%
Q4 2022$272,280
+244.7%
28,9660.0%0.00%
Q3 2022$79,000
-38.8%
28,966
-34.9%
0.00%
Q2 2022$129,000
-78.1%
44,466
-77.4%
0.00%
Q1 2022$590,000
-27.7%
196,410
+10.8%
0.00%
Q4 2021$816,000
-24.5%
177,326
+3.0%
0.00%
Q3 2021$1,081,000
+5.2%
172,095
+0.3%
0.00%
Q2 2021$1,028,000
-2.4%
171,539
+3.1%
0.00%
Q1 2021$1,053,000
+20.5%
166,455
+7.3%
0.00%
Q4 2020$874,000
-3.4%
155,083
-0.2%
0.00%
Q3 2020$905,000
-22.3%
155,347
-3.8%
0.00%
-100.0%
Q2 2020$1,165,000
+48.0%
161,478
-4.0%
0.00%
Q1 2020$787,000
-40.5%
168,153
+1.9%
0.00%
-100.0%
Q4 2019$1,323,000
+18.3%
164,950
+1.6%
0.00%0.0%
Q3 2019$1,118,000
-9.3%
162,368
+9.5%
0.00%0.0%
Q2 2019$1,232,000
-8.0%
148,347
+10.2%
0.00%0.0%
Q1 2019$1,339,000
+35.4%
134,655
+4.2%
0.00%0.0%
Q4 2018$989,000
-49.0%
129,182
+16.0%
0.00%0.0%
Q3 2018$1,941,000
+121.8%
111,382
+20.9%
0.00%0.0%
Q2 2018$875,00092,1000.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders